Translational research: From observational studies to health policy: How a cohort study can help improve outcomes after stroke

Stroke

Volumn 42, Issue 12, 2011, Pages 3336-3337

  Saposnik, Gustavo ^a,b,c   Estol, Conrado J ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d Neurological Center   (Argentina)

Author keywords

Health indicators; Health policy; Organized stroke care; Outcomes; Outcomes research; Performance; Process measures; Public policy; Stroke management

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAZIL; CARDIOVASCULAR RISK; COHORT ANALYSIS; DIABETES MELLITUS; DIGITAL SUBTRACTION ANGIOGRAPHY; ECHOCARDIOGRAPHY; EDITORIAL; ELECTROCARDIOGRAPHY; HEALTH CARE ACCESS; HEALTH CARE POLICY; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; STROKE; SUBARACHNOID HEMORRHAGE; TRANSLATIONAL RESEARCH;

BRAIN ISCHEMIA; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; FEMALE; HUMANS; MALE; STROKE;

EID: 84856235940     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.636563     Document Type: Editorial

References (15)

1. Cruz-Flores S, Rabinstein A, Biller J, Elkind MS, Griffith P, Gorelick PB, et al. Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2091-2116.
2. Fonarow GC, Reeves MJ, Smith EE, Saver JL, Zhao X, Olson DW, et al. Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in Get With The Guidelines-Stroke. Circ Cardiovasc Qual Outcomes. 2011;3:291-302.
3. World Health Organization. Cardiovascular diseases. Facts Sheet #317. January 2011. Available at: www.who.int/mediacentre/factsheets/fs317/en/index. html. Accessed August 24, 2011.
4. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007;370:1929-1938. (Pubitemid 350192633)
5. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8:355-369.
6. Sposato L, Saposnik G. Gross domestic product and health expenditure associated with incidence, 30-day fatality and age at stroke onset: a systematic review. Stroke. 2011;42: Epub ahead of print, October 27, 2011.
7. de Carvalho J J F, Alves MB, Viana G A A, Machado CB, dos Santos B F C, Kanamura AH, et al. Stroke epidemiology, patterns of management, and outcomes in Fortaleza, Brazil: a hospital-based multicenter prospective study. Stroke. 2011;42:3341-3346.
8. Sposato LA, Esnaola MM, Zamora R, Zurru MC, Fustinoni O, Saposnik G. Quality of ischemic stroke care in emerging countries: the Argentinian national stroke registry (Renacer). Stroke. 2008;39:3036-3041.
9. Heuschmann PU, Kolominsky-Rabas PL, Roether J, Misselwitz B, Lowitzsch K, Heidrich J, et al. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. JAMA. 2004;292:1831-1838. (Pubitemid 40169293)
10. Saposnik G, Black SE, Hakim A, Fang J, Tu JV, Kapral MK. Age disparities in stroke quality of care and delivery of health services. Stroke. 2009;40:3328-3335.
11. Estol CJ, Esnaola y Rojas MM. Stroke in Argentina. Int J Stroke. 2010;5:35-39.
12. Hollenbeak CS, Gorton CP, Tabak YP, Jones JL, Milstein A, Johannes RS. Reductions in mortality associated with intensive public reporting of hospital outcomes. Am J Med Qual. 2008;23:279-286.
13. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-1516. (Pubitemid 46588415)
14. Spence JD, Coates V, Li H, Tamayo A, Munoz C, Hackam DG, et al. Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol. 2010;67:180-186.
15. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003;326:1419.